Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults : a multi-country analysis
Source
BMC medicine - ISSN 1741-7015-23:1 (2025) p. 1-17
Management cost of acute respiratory infections in older adults in China : a systematic review and meta-analysis
Source
Journal of Global Health - ISSN 2047-2978-14 (2024) p. 1-10
Pricey or priceless : cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
Source
The Lancet regional health. Americas - ISSN 2667-193X-29 (2024) p. 1-2
COVID-19-related health utility values and changes in COVID-19 patients and the general population : a scoping review
Source
Quality of life research - ISSN 0962-9343-33:6 (2024) p. 1443-1454
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022
Source
Vaccine - ISSN 0264-410X-41:48 (2023) p. 7047-7059